BSX   $84.201  1.96% Market Open

Boston Scientific Corp
Total Cash 2.91B
totalCashPerShare 1.978
EBITDA 3.95B
Total Debt 10.94B
quickRatio 0.953
currentRatio 1.612
Total Revenue 15.23B
debtToEquity 53.064
Revenue/Share 10.379
ROA 0.04808
ROE 0.093210004
grossProfits
freeCashflow 1.61B
operatingCashflow 2.63B
earningsGrowth 0.22
revenueGrowth 0.145
grossMargins 0.68691003
ebitdaMargins 0.25924
operatingMargins 0.19393
profitMargins 0.119969994
enterpriseValue 130.95B
forwardPE 30.516483
floatShares 1.47B
sharesOutstanding 1.47B
sharesShort 11.02M
sharesShortPriorMonth 10.80M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.93%
Short Ratio help_outline 2.24%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 13.848
Price To Book help_outline 6.02
earningsQuarterlyGrowth 0.20
netIncomeToCommon 1.83B
trailingEps 1.23%
forwardEps 2.73%
enterpriseToEbitda 33.17
lastDividendValue
lastDividendDate
currentQuarterEstimate 0.59 3Q 2024
institutionsCount 1913
lastUpdated Sept. 16, 2024, 11:53 a.m.